Eris Lifesciences stock is traded under the ticker #ERIS. Below you can review Eris Lifesciences stock performance in the past 12 months up to November 2025

Total visits to Eris Lifesciences's top domains

Understand Eris Lifesciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

eris.co.in25K

oaknethealthcare.com12.9K

swiss.in1.3K

See more with Sales Intelligence

Avg. visit duration in Eris Lifesciences's top domains

Analyze Eris Lifesciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

eris.co.in00:01:07

oaknethealthcare.com00:00:28

swiss.in00:00:08

See more with Sales Intelligence

Avg. pageviews on Eris Lifesciences's top domains

See how Eris Lifesciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

eris.co.in2.04

oaknethealthcare.com2.78

swiss.in1.53

See more with Sales Intelligence

Eris Lifesciences top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ftindia.comCompany NameFinancial Technologies (India) Ltd.Employees1001 - 5000HQIndia, MumbaiAnnual revenue$50M - $75MTotal visits--Finance > Investing

Top technologies used by Eris Lifesciences

These are the website technologies, by industry, used by Eris Lifesciences top domains

Widget (7)

Twemoji

Audio Video Media (3)

YouTube

Social (3)

Instagram

Advertising (2)

DoubleClick

More Technologies

6

See all

News & Signals from Eris Lifesciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEris Lifesciences Pvt. Ltd. hired Murari Ranganathan as President of the cardiometabolic Business on Mar 6th '25.New Delhi, March 6, 2025: Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company has appointed Mr. Murari Ranganathan as President of the cardiometabolic Business.

NewsEris Lifesciences Pvt. Ltd. acquires Biocon Biologics Limited for $150M.Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore.

NewsEris Lifesciences Pvt. Ltd. acquires Biocon Biologics Ltd for $150M.Eris Lifesciences has entered into a definitive agreement to acquire the India-branded formulation business of Biocon Biologics for ₹1,242 crore, a move that strengthens its footprint in the domestic injectables segment, and catapults it into the top bracket of the insulin segment.